Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00843856Phase 4Completed
Phase 4, randomised, open-label trial of mycophenolate mofetil in membranous glomerulonephritis (MGN), sponsored by Imperial College Healthcare NHS Trust. Started Mar 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00843856.